Conference abstractPublished 2 May 2016
The place for early use of long acting injectables in managing schizophrenia... An Australian Clinician's experience and viewpoint
Australian National University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Injectable medications have often been viewed as a last resort or when definitive non-adherence is clearly apparent. Debates about treatment resistance or resistance to treatment can delay the pragmatic need to discuss injections as an option. The consideration of injectables early in the course of the illness ensures effective treatment and in many cases a paradoxical opportunity to engage the patient, bring back control of the situation, reduce symptoms and restore/improve cognition. This can then be seen as a positive response to managing a difficult illness instead of the step of failures in moving away from oral medications that have been ineffective for whatever reason. In this presentation, there will be an historical summary of schizophrenia treatments followed by the case for injectables. Case studies will illustrate the options for treatment at a number of illness stages.
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “Peter Norrie”